Stocks
Amicus Therapeutics (FOLD) Debt/EBITDA US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| Debt/EBITDA | 0.73 | 0.17 | 0.21 | -0.79 | -1.73 | -21.2 | ||
| Changes by years, y/y, % | +27% | -77% | +22% | -480% | +117% | |||
Amicus Therapeutics. Debt/EBITDA
Amicus Therapeutics. Debt/EBITDA, changes, %
Amicus Therapeutics (FOLD) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Debt/EBITDA | -1.34 | -1.76 | -2.58 | -4.56 | -21.2 | -21.2 | ||
| Changes by years, y/y, % | +188% | +113% | +130% | +238% | +1 481% | |||
| Changes by quarters, q/q, % | -1% | +31% | +47% | +77% | +365% | |||
